Search

everythinglearnresearchcommunity

for

Search:↓

Panitumumab can cause excessive ear hair growth.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

A mother's diet at conception can cause lasting genetic changes in her child.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The niche environment controls stem cell behavior and plasticity, which is important for tissue health and repair.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Topical minoxidil not effective for erectile dysfunction treatment.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.